Reply
Peter Van den Bergh MD, PhD
Department of Neurology, Neuromuscular Reference Centre, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium
Search for more papers by this authorPhilippe Hantson MD, PhD
Department of Intensive Care, Cliniques St-Luc, Université Catholique de Louvain, Brussels, Belgium
Search for more papers by this authorLuc Kevers MD
Department of Neurology, Cliniques St-Jean, Brussels, Belgium
Search for more papers by this authorNicole Fabien PhD
University of Lyon, F690002 Lyon, France
Hospices Civils de Lyon, Department of Autoimmunity & Immunology, Centre Hospitalier Lyon-Sud, F-69495 Pierre-Benite, France
INSERM U851, F-690007, France
Search for more papers by this authorPeter Van den Bergh MD, PhD
Department of Neurology, Neuromuscular Reference Centre, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium
Search for more papers by this authorPhilippe Hantson MD, PhD
Department of Intensive Care, Cliniques St-Luc, Université Catholique de Louvain, Brussels, Belgium
Search for more papers by this authorLuc Kevers MD
Department of Neurology, Cliniques St-Jean, Brussels, Belgium
Search for more papers by this authorNicole Fabien PhD
University of Lyon, F690002 Lyon, France
Hospices Civils de Lyon, Department of Autoimmunity & Immunology, Centre Hospitalier Lyon-Sud, F-69495 Pierre-Benite, France
INSERM U851, F-690007, France
Search for more papers by this author
References
- 1 Hantson P, Kevers L, Fabien N, van den Bergh P. Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies. Muscle Nerve 2010; 41: 423–426.
- 2 Ruts L, Drenthen J, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain–Barré syndrome: a prospective study. Neurology 2010; 74: 1680–1686.
- 3 Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 2009; 80: 56–59.
- 4 Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision. Eur J Neurol 2010; 17: 356–363.
- 5 Hughes RA, van der Meché FG. Corticosteroids for treating Guillain–Barré syndrome. Cochrane Database Syst Rev 2000 (3): CD001446.
- 6 Alexander KJ, Alshubaili AF, Santhamoorthy P, Sharafuddin KM. Corticosteroids can help distinguish between Guillain–Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report. Med Princ Pract 2008; 17: 422–424.
